Oculis Holding AG
OCS28.480USD
+0.990+3.60%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
1.59B시가총액
손실P/E TTM
자세한 내용은 Oculis Holding AG 회사
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
Oculis Holding AG 정보
종목 코드 OCS
회사 이름Oculis Holding AG
상장일Mar 03, 2023
CEOSherif (Riad)
직원 수49
유형Ordinary Share
회계 연도 종료Mar 03
주소Bahnhofstrasse 20
도시ZUG
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Switzerland
우편 번호6300
전화41417113960
웹사이트https://oculis.com/
종목 코드 OCS
상장일Mar 03, 2023
CEOSherif (Riad)
Oculis Holding AG의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
+470969.00%
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
268.83K
+19603.00%
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
72.06K
+5254.00%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
+20593.00%
Dr. Riad Sherif, M.D.
Dr. Riad Sherif, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Anthony A. (Tony) Rosenberg
Mr. Anthony A. (Tony) Rosenberg
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
--
-11718.00%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
--
--
Mr. Arshad M. Khanani, M.D.
Mr. Arshad M. Khanani, M.D.
Independent Director
Independent Director
--
--
Mr. Robert K. Warner
Mr. Robert K. Warner
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
+470969.00%
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
268.83K
+19603.00%
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
72.06K
+5254.00%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
+20593.00%
Dr. Riad Sherif, M.D.
Dr. Riad Sherif, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Anthony A. (Tony) Rosenberg
Mr. Anthony A. (Tony) Rosenberg
Independent Chairman of the Board
Independent Chairman of the Board
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Tue, Feb 3
마지막 업데이트: Tue, Feb 3
주주
주주 유형
주주
주주
비율
EQT Partners AB
10.21%
EQT Life Sciences
9.95%
Earlybird Venture Capital
4.40%
Gildi - lífeyrissjóður
4.23%
Pivotal Bioventure Partners Investment Advisor LLC
3.98%
기타
67.23%
주주
주주
비율
EQT Partners AB
10.21%
EQT Life Sciences
9.95%
Earlybird Venture Capital
4.40%
Gildi - lífeyrissjóður
4.23%
Pivotal Bioventure Partners Investment Advisor LLC
3.98%
기타
67.23%
주주 유형
주주
비율
Venture Capital
23.74%
Private Equity
10.21%
Investment Advisor/Hedge Fund
4.34%
Pension Fund
4.23%
Individual Investor
2.75%
Investment Advisor
2.00%
Hedge Fund
0.57%
Research Firm
0.07%
기타
52.08%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
57
26.09M
45.14%
+9.72M
2025Q3
49
16.42M
28.41%
+792.94K
2025Q2
51
19.48M
37.42%
+1.76M
2025Q1
51
19.44M
37.35%
+1.93M
2024Q4
86
15.00M
31.97%
-10.87M
2024Q3
87
16.29M
41.43%
-9.17M
2024Q2
88
16.63M
42.28%
-9.14M
2024Q1
91
16.14M
42.22%
-11.25M
2023Q4
93
17.20M
46.87%
-6.97M
2023Q3
92
16.51M
48.34%
-4.37M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
EQT Partners AB
5.90M
10.21%
+5.90M
--
Sep 30, 2025
EQT Life Sciences
5.75M
9.95%
+425.53K
+7.99%
Dec 31, 2024
Earlybird Venture Capital
2.54M
4.4%
+2.54M
--
Dec 31, 2024
Pivotal Bioventure Partners Investment Advisor LLC
2.30M
3.98%
--
--
Sep 30, 2025
BVCF Management, Ltd.
2.19M
3.79%
+121.79K
+5.88%
Nov 27, 2024
abrdn Inc.
1.25M
2.17%
--
--
Sep 30, 2025
Sherif (Riad M.D.)
644.75K
1.12%
-233.73K
-26.61%
Dec 31, 2024
Wellington Management Company, LLP
513.66K
0.89%
-789.00
-0.15%
Nov 30, 2025
Nan Fung Life Sciences
514.70K
0.89%
--
--
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Tue, Dec 2
마지막 업데이트: Tue, Dec 2
이름
비율
Simplify Propel Opportunities ETF
2.81%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.12%
Even Herd Long Short ETF
0%
Simplify Propel Opportunities ETF
비율2.81%
SPDR SSGA US Small Cap Low Volatility Index ETF
비율0.12%
Even Herd Long Short ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
